AEM.T 68.80 (+1.04 | +1.53%) AEM 65.30 (+0.84 | +1.30%) TCM.T 9.67 (+0.05 | +0.52%) TC 9.17 (+0.02 | +0.22%) ERF.UN.T 24.86 (+0.30 | +1.22%) ERF 23.61 (+0.30 | +1.29%) GZM.UN.T 16.79 (-0.04 | -0.24%) FM.T 64.50 (-0.46 | -0.71%) MDI.T 25.21 (+0.06 | +0.24%) OSK.T 13.82 (+0.13 | +0.95%) ARZ.T 6.92 (+0.03 | +0.44%) AZK 6.57 (0.00 | 0.00%) CG.T 15.13 (+0.26 | +1.75%) ST.T 0.87 (+0.01 | +1.16%) BWR.T 3.93 (0.00 | 0.00%) CLQ.T 0.56 (-0.02 | -3.45%) CLQMD.O 0.58 (0.00 | 0.00%) RME.T 8.29 (-0.13 | -1.54%) BRD.T 1.36 (+0.05 | +3.82%) BRD 1.28 (+0.04 | +3.23%) R.V 1.82 (+0.02 | +1.11%) TWT.T 3.43 (0.00 | 0.00%) GPD.T 0.58 (+0.03 | +5.45%) WOF.V 0.11 (+0.01 | +5.00%) PCC.T 2.51 (+0.03 | +1.21%) MSQ.V 0.88 (-0.01 | -1.12%) I.T 2.42 (0.00 | 0.00%) IPCI 2.32 (+0.01 | +0.43%) XME.V 0.20 (0.00 | 0.00%) STG.V 0.18 (+0.01 | +6.06%) MXI.V 0.50 (+0.01 | +2.04%) NIF.UN.T 3.80 (-0.30 | -7.32%) RSC.T 0.50 (0.00 | 0.00%) BCU.V 0.21 (-0.01 | -4.55%) GOD.V 0.11 (0.00 | 0.00%) FT.T 0.60 (-0.01 | -1.64%) GBK.V 0.34 (-0.01 | -1.47%) GSL.T 4.20 (-0.12 | -2.78%) LRI.T 0.34 (+0.05 | +17.24%) AHF.V 1.21 (-0.02 | -1.63%) AMZ.V 2.13 (-0.07 | -3.18%) MBA 0.51 (-0.01 | -1.92%) VHV.V 0.61 (0.00 | 0.00%) MWC.T 0.26 (-0.01 | -1.92%) LMA.T 1.90 (-0.01 | -0.52%) EE.T 1.03 (0.00 | 0.00%) EET.T 0.46 (-0.01 | -1.09%) PRM.V 0.05 (0.00 | 0.00%) APA.V 0.14 (+0.01 | +3.85%) GGR.V 0.27 (-0.01 | -3.64%) CBE.V 0.17 (0.00 | 0.00%) GMX.T 1.58 (+0.07 | +4.64%) GLBXF.O 1.47 (0.00 | 0.00%) SMF.T 8.70 (+0.05 | +0.58%) SVT.V 0.15 (+0.01 | +3.57%)

Medwell Capital Corp.

MWC.T (TSX)
$0.26aaa
Change -0.01 -1.92%
Volume 167,570
52 week Low Hi
  $0.26 $0.43
Financial Information
Shares Outstanding: 91,008,923
Fully Diluted Shares: 127,259,451
Est. Market Float: -
Market Cap.: $23,207,275
EPS last 3 months: $(0.10)
EPS Trailing 12 months: $(0.03)
Long-Term Debt: -
Financial Year-End: Dec 31
Updated: 2010-09-02 13:20:22
15-20 mimutes delay

Renmark Financial Disclaimer

The information contained above was approved by the company presented and is reproduced with its authorization. The accuracy and completeness of that information are the sole responsibility of the said company.

This document is published for general information only and it should not be interpreted as an investment recommendation nor an offer or a solicitation to buy or sell securities issued by the said company. Renmark does not and will not accept any responsibility or liability for investment decisions made on the basis of the information herein contained.
Sep 21, 2010 - 1:00 PM PDT
Medwell Capital Corp.
Vancouver Corporate Presentation
Sep 22, 2010 - 12:00 PM MDT
Medwell Capital Corp.
Calgary Corporate Presentation
Sep 23, 2010 - 12:00 PM MDT
Medwell Capital Corp.
Edmonton Corporate Presentation
Oct 19, 2010 - 12:00 PM EDT
Medwell Capital Corp.
Ottawa Corporate Presentation
Aug 12, 2010
application/pdf icon
Second Quarter 2010
May 14, 2010
application/pdf icon
First Quarter 2010
Mar 16, 2010
application/pdf icon
2009 Annual Report
Nov 12, 2009
application/pdf icon
Third Quarter 2009

Medwell Capital Corp. (formally named BioMS Medical Corp.) is a Canadian-based service provider in the healthcare industry, whereby Medwell Capital directly invests in and advises companies on strategy, financing, mergers & acquisitions (M&A), and licensing transactions and undertakes technology development.

Medwell Capital prides itself with an experienced scientific, clinical and business development team, the strategic and financial network of its partners, and the close relationships developed with numerous healthcare companies and management.

Kevin Giese, President & Chief Executive Officer

Dr. Kjell Stenberg, Chief Operating Officer

Brent Johnston, Chief Financial Officer

Tony Hesby, Executive Vice-President

Richard Brown, Vice-President, Commercial Development

Dr. Tony Verco, Vice-President, Drug Development

Randy Stroud, Vice-President, Regulatory Affairs

Ryan Giese, Vice-President, Corporate Communications

Clifford Giese, Chairman

Kevin Giese, Director

Dr. Kjell Stenberg, Director

Laine Wollard, Director

Dr. John Wetherell, Director

William D. Grace, Director

Gordon Politeski, Director

Headquarters:

8812 - 60 Avenue
Edmonton, Alberta
T6E 6A6 Canada

Telephone: (780) 413-7152
Fax: (780) 408-3040

For additional info., contact
Christine Stewart
Barry Mire

Montréal

Telephone: (514) 939-3989
Fax: (514) 939-3717

Toronto

Telephone: (416) 644-2020
Fax: (416) 644-2021
Home Medwell Capital Corp.